The Lipid Panel with Ratios test aids in evaluating cardiovascular disease (CVD) risk and the likelihood of an ischemic event.

Clinical Significance

This panel measures serum cholesterol and triglyceride (TG) levels. It includes evaluation of the LDL/HDL ratio (calculated), cholesterol/HDL-C ratio (calculated), HDL-C, LDL-C (calculated), non-HDL-C (calculated), total cholesterol, and TG. Comprehensive lipid assessment aids in evaluating cardiovascular disease (CVD) risk and the likelihood of an ischemic event. It is also useful for the prevention and management of atherosclerotic disease and diagnosis of metabolic syndrome.

CVD is the leading cause of death in the United States. Individuals with high LDL-C and TG levels are at elevated risk for developing CVD and having an ischemic event. The American Heart Association recommends that Americans aged 20 and above have their lipid levels tested every 4 to 6 years. Children should have their cholesterol tested for the first time between ages 9 and 11 and again between ages 17 and 21. Testing should start earlier if there is a family history of high cholesterol.

This panel reports a calculated LDL/HDL ratio in addition to all the components included in a standard Lipid Panel. High LDL/HDL ratio may be a stronger predictor of coronary heart disease than LDL and HDL alone in patients with hypertriglyceridemia.